Cost-Effectiveness of a Polygenic Risk Score Based Breast Cancer Screening Program in Estonia

被引:0
|
作者
Sampaio, Filipa [1 ]
Padrik, Peeter [2 ]
Kruuv-Kao, Krista [2 ,3 ]
Koiduaru, Katrin
Tonisson, Neeme [4 ,5 ]
Feldman, Inna [1 ]
机构
[1] Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden
[2] OU Antegenes, Tartu, Estonia
[3] Univ Tartu, Inst Family Med & Publ Hlth, Tartu, Estonia
[4] Univ Tartu, Inst Genom, Tartu, Estonia
[5] Tartu Univ Hosp, Genet & Personalized Med Clin, Tartu, Estonia
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
P18.018.A
引用
收藏
页码:1704 / 1704
页数:1
相关论文
共 50 条
  • [1] Cost-effectiveness of using artificial intelligence versus polygenic risk score to guide breast cancer screening
    Mital, Shweta
    Nguyen, Hai, V
    BMC CANCER, 2022, 22 (01)
  • [2] Cost-effectiveness of using artificial intelligence versus polygenic risk score to guide breast cancer screening
    Shweta Mital
    Hai V. Nguyen
    BMC Cancer, 22
  • [3] Cost-effectiveness of a breast cancer screening program in Switzerland
    Salvi, I.
    BREAST, 2025, 80
  • [4] Cost-effectiveness of the Norwegian breast cancer screening program
    van Luijt, P. A.
    Heijnsdijk, E. A. M.
    de Koning, H. J.
    INTERNATIONAL JOURNAL OF CANCER, 2017, 140 (04) : 833 - 840
  • [5] Cost-Effectiveness of Personalized Screening for Colorectal Cancer Based on Polygenic Risk and Family History
    Cenin, Dayna R.
    Naber, Steffie K.
    de Weerdt, Anne C.
    Jenkins, Mark A.
    Preen, David B.
    Hooi, C. Ee
    O'Leary, Peter C.
    Lansdorp-Vogelaar, Iris
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2020, 29 (01) : 10 - 21
  • [6] COST-EFFECTIVENESS OF BREAST CANCER SCREENING PROGRAM IN THE REPUBLIC OF KAZAKHSTAN
    Salikhanov, I
    Crape, B. L.
    Howie, P.
    VALUE IN HEALTH, 2018, 21 : S169 - S169
  • [7] A cost-effectiveness analysis of lung cancer screening with low-dose computed tomography and a polygenic risk score
    Zhao, Zixuan
    Gu, Shuyan
    Yang, Yi
    Wu, Weijia
    Du, Lingbin
    Wang, Gaoling
    Dong, Hengjin
    BMC CANCER, 2024, 24 (01)
  • [8] A cost-effectiveness analysis of lung cancer screening with low-dose computed tomography and a polygenic risk score
    Zixuan Zhao
    Shuyan Gu
    Yi Yang
    Weijia Wu
    Lingbin Du
    Gaoling Wang
    Hengjin Dong
    BMC Cancer, 24
  • [9] Polygenic risk-tailored screening for prostate cancer: A cost-effectiveness analysis
    Callender, Thomas
    Emberton, Mark
    Morris, Steve
    Eeles, Ros
    Kote-Jarai, Zsofia
    Pharoah, Paul
    Pashayan, Nora
    CANCER RESEARCH, 2019, 79 (13)
  • [10] Cost-effectiveness analysis of implementing polygenic risk score in a workplace cardiovascular disease prevention program
    Mujwara, Deo
    Kintzle, Jen
    Di Domenico, Paolo
    Busby, George B.
    Botta, Giordano
    FRONTIERS IN PUBLIC HEALTH, 2023, 11